Side-by-side comparison of AI visibility scores, market position, and capabilities
Redwood City ambient voice AI for physicians converting patient conversations into EHR-coded SOAP notes and diagnoses; integrates with major EHR systems to reduce documentation time.
Suki AI is a Redwood City-based clinical AI company that provides physicians with an ambient voice assistant that listens to patient-physician conversations during appointments and automatically generates structured clinical notes in the EHR, dramatically reducing the documentation burden that contributes to physician burnout. Suki's AI processes natural conversation audio to extract clinically relevant information, populate SOAP notes, and code diagnoses and procedures — turning a 15-minute documentation task into a 2-minute review and sign-off. The platform integrates with major EHR systems including Epic, Cerner, and Athena and is designed to fit naturally into clinical workflows without requiring physicians to change how they see patients. Suki serves health systems, physician groups, and telehealth companies looking to improve clinician efficiency and satisfaction. Founded in 2017 by former Google and Flipkart executives, Suki raised over $165M from investors including Venrock, First Round Capital, and Flare Capital Partners. It competes with Nuance DAX, Abridge, and DeepScribe in the ambient AI documentation market.
ResMed (RMD) reported ~$4.7B revenue in FY2024. Global leader in cloud-connected devices for sleep apnea, COPD, and out-of-hospital care, with 10M+ connected devices. HQ: San Diego.
ResMed Inc. is the global leader in cloud-connected medical devices and software for diagnosing and treating sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions in out-of-hospital settings. Founded in Sydney, Australia in 1989, the company designs and manufactures CPAP (continuous positive airway pressure) machines, masks, ventilators, and related accessories used by patients with obstructive sleep apnea — a condition affecting approximately 1 billion people globally that is chronically under-diagnosed and under-treated.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.